CRISPR/Cas9 genome-wide sgRNA libraries for loss-of-function and gain-of-function genetic screens

被引：0
|
作者：
Tedesco, Donato
Diehl, Paul
Makhanov, Mikhail
Baron, Sylvain
Chenchik, Alex
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Genome-wide CRISPR/Cas9 screening for drug resistance in tumors
    Zhang, Zhongyan
    Wang, Hailiang
    Yan, Qian
    Cui, Jinwei
    Chen, Yubin
    Ruan, Shiye
    Yang, Jiayu
    Wu, Zelong
    Han, Mingqian
    Huang, Shanzhou
    Zhou, Qi
    Zhang, Chuanzhao
    Hou, Baohua
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [22] Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases
    Shengdar Q. Tsai
    J. Keith Joung
    Nature Reviews Genetics, 2016, 17 : 300 - 312
  • [23] Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique
    Zhang, Beibei
    Zhou, Jiamu
    Li, Miao
    Wei, Yuanmeng
    Wang, Jiaojiao
    Wang, Yange
    Shi, Pingling
    Li, Xiaoli
    Huang, Zixu
    Tang, He
    Song, Zongming
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2021, 413 (09) : 2447 - 2456
  • [24] Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique
    Beibei Zhang
    Jiamu Zhou
    Miao Li
    Yuanmeng Wei
    Jiaojiao Wang
    Yange Wang
    Pingling Shi
    Xiaoli Li
    Zixu Huang
    He Tang
    Zongming Song
    Analytical and Bioanalytical Chemistry, 2021, 413 : 2447 - 2456
  • [25] Genome-wide CRISPR/Cas9 screens for the identification of novel YAP1/TAZ modulators.
    Naujoks, Jan
    Potze, Lisette
    Kuehnlenz, Julia
    Kamburov, Atanas
    Nevedomskaya, Ekaterina
    Steffen, Andreas
    Luther, Claudia
    Anurin, Anna
    Buttgereit, Anne
    Prechtl, Stefan
    Bader, Benjamin
    Lesche, Ralf
    Staller, Peter
    Lange, Martin
    Nicke, Barbara
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 36 - 36
  • [26] LEVERAGING GENOME-WIDE CRISPR/CAS9 KNOCKOUT DRUG SCREENS TO IDENTIFY SENSITIZERS FOR PROTEOSOME INHIBITORS IN GLIOBLASTOMA
    Anand, Alisha
    Shaikh, Muhammad Vaseem
    Chokshi, Chirayu
    Brakel, Benjamin
    Maich, Will
    Grewal, Shan
    Venugopal, Chitra
    Singh, Sheila
    NEURO-ONCOLOGY, 2024, 26
  • [27] Genome Editing in Plants Using CRISPR/Cas9/sgRNA Technologies
    Weeks, Donald P.
    Jiang, Wenzhi
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2014, 50 : S21 - S21
  • [28] Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells
    Mariangela Pappadà
    Ottavia Bonuccelli
    Mattia Buratto
    Riccardo Fontana
    Mariaconcetta Sicurella
    Anna Caproni
    Silvia Fuselli
    Andrea Benazzo
    Roberto Bertorelli
    Veronica De Sanctis
    Paolo Cavallerio
    Valentina Simioni
    Valeria Tugnoli
    Francesca Salvatori
    Peggy Marconi
    Scientific Reports, 12 (1)
  • [29] Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells
    Pappada, Mariangela
    Bonuccelli, Ottavia
    Buratto, Mattia
    Fontana, Riccardo
    Sicurella, Mariaconcetta
    Caproni, Anna
    Fuselli, Silvia
    Benazzo, Andrea
    Bertorelli, Roberto
    De Sanctis, Veronica
    Cavallerio, Paolo
    Simioni, Valentina
    Tugnoli, Valeria
    Salvatori, Francesca
    Marconi, Peggy
    SCIENTIFIC REPORTS, 2022, 12 (01):
  • [30] Albumin -conjugated drug is irresistible by single gene mutation of endocytic system: Verification by genome-wide CRISPR-Cas9 loss -of -function screens
    Yuan, Fang
    Sun, Mengnan
    Liu, Huiqin
    Qian, Feng
    JOURNAL OF CONTROLLED RELEASE, 2020, 323 : 311 - 320
12345